Literature DB >> 19631670

Protective effect of creatine against RNA damage.

Carmela Fimognari1, Piero Sestili, Monia Lenzi, Giorgio Cantelli-Forti, Patrizia Hrelia.   

Abstract

It is well documented that damage to DNA could be very harmful for all cells and is the source of several consequences such as cancer development, apoptosis or genetic diseases. In contrast, RNA damage is a poorly examined field in biomedical research, despite its potential to affect cell physiology. For example, a significant loss of RNA integrity has been demonstrated in advanced human atherosclerotic plaques as compared with non-atherosclerotic mammary arteries, and oxidative RNA damage has been described in several neurodegenerative diseases including Alzheimer disease. In the present study, we investigated whether RNA damage could be related to the exposure of particular xenobiotics and then we studied the potential protective activity of creatine against RNA-damaging activity of a series of chemicals with different mechanisms of action [ethyl methanesulfonate (EMS), H(2)O(2), doxorubicin, spermine NONOate, S-nitroso-N-acetylpenicillamine (SNAP)]. Since the protective effect against RNA damage can be mediated by different mechanisms, such as alterations of the rates of toxic agent absorption and uptake, trapping of electrophiles as well as free radicals, and protection of nucleophilic sites in RNA, we used two different treatment protocols (pre- and co-treatment) for understanding the mechanism of the inhibitory activity of creatine. We demonstrated that total RNA is susceptible to chemical attack by doxorubicin, H(2)O(2), spermine and SNAP. Creatine significantly reduced the RNA-damaging activity of only two of the toxic tested agents (H(2)O(2) and doxorubicin), while it lacked activity in counterstaining the RNA damage induced by the NO donors spermine and SNAP. Its inhibitory activity could be at least partially dependent on its capacity to directly scavenge free radicals and/or to maintain phosphocreatine store and ATP regeneration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19631670     DOI: 10.1016/j.mrfmmm.2009.07.005

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  16 in total

1.  Creatine supplementation in Walker-256 tumor-bearing rats prevents skeletal muscle atrophy by attenuating systemic inflammation and protein degradation signaling.

Authors:  Paola S Cella; Poliana C Marinello; Fernando H Borges; Diogo F Ribeiro; Patrícia Chimin; Mayra T J Testa; Philippe B Guirro; José A Duarte; Rubens Cecchini; Flávia A Guarnier; Rafael Deminice
Journal:  Eur J Nutr       Date:  2019-02-26       Impact factor: 5.614

2.  Serum Creatinine Protects Against Amyotrophic Lateral Sclerosis: a Mendelian Randomization Study.

Authors:  Mengmeng Wang; Dandan Liu; Zhizhong Zhang; Wei Xie; Liping Cao; Linfeng Zhu; Meng Liu; Shiying Sheng; Xuegan Lian
Journal:  Mol Neurobiol       Date:  2021-02-08       Impact factor: 5.590

3.  Creatine attenuates seizure severity, anxiety and depressive-like behaviors in pentylenetetrazole kindled mice.

Authors:  Emmanuel O Okwuofu; Gbenga E Ogundepo; Abigail M Akhigbemen; Akinpelu L Abiola; Raymond I Ozolua; Ighodaro Igbe; Ononiwu Chinazamoku
Journal:  Metab Brain Dis       Date:  2021-02-09       Impact factor: 3.584

Review 4.  Exercise and nutritional interventions for improving aging muscle health.

Authors:  Scott C Forbes; Jonathan P Little; Darren G Candow
Journal:  Endocrine       Date:  2012-04-21       Impact factor: 3.633

5.  Creatine supplementation decreases plasma lipid peroxidation markers and enhances anaerobic performance in rats.

Authors:  Rafael Deminice; Alceu Afonso Jordao
Journal:  Redox Rep       Date:  2016-02-15       Impact factor: 4.412

6.  ZAK is required for doxorubicin, a novel ribotoxic stressor, to induce SAPK activation and apoptosis in HaCaT cells.

Authors:  Kristin A D Sauter; Eli A Magun; Mihail S Iordanov; Bruce E Magun
Journal:  Cancer Biol Ther       Date:  2010-08-13       Impact factor: 4.742

7.  SLC6A8-mediated intracellular creatine accumulation enhances hypoxic breast cancer cell survival via ameliorating oxidative stress.

Authors:  Qiao Li; Manran Liu; Yan Sun; Ting Jin; Pengpeng Zhu; Xueying Wan; Yixuan Hou; Gang Tu
Journal:  J Exp Clin Cancer Res       Date:  2021-05-14

8.  Sulforaphane potentiates RNA damage induced by different xenobiotics.

Authors:  Carmela Fimognari; Monia Lenzi; Piero Sestili; Eleonora Turrini; Lorenzo Ferruzzi; Patrizia Hrelia; Giorgio Cantelli-Forti
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240

Review 9.  Role of Oxidative RNA Damage in Chronic-Degenerative Diseases.

Authors:  Carmela Fimognari
Journal:  Oxid Med Cell Longev       Date:  2015-05-20       Impact factor: 6.543

10.  Phosphocreatine interacts with phospholipids, affects membrane properties and exerts membrane-protective effects.

Authors:  Malgorzata Tokarska-Schlattner; Raquel F Epand; Flurina Meiler; Giorgia Zandomeneghi; Dietbert Neumann; Hans R Widmer; Beat H Meier; Richard M Epand; Valdur Saks; Theo Wallimann; Uwe Schlattner
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.